The CSF concentration of ADMA, but not of ET-1, is correlated with the occurrence and severity of cerebral vasospasm after subarachnoid hemorrhage

Neuroscience Letters

Volumn 524, Issue 1, 2012, Pages 20-24

  Jung, Carla S ^a,b   Lange, Bettina ^a   Zimmermann, Michael ^a   Seifert, Volker ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ADMA; Endothelin 1; Nitric oxide; Nitric oxide synthase inhibitor; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ENDOTHELIN 1; N(G),N(G) DIMETHYLARGININE;

ADULT; ARTERIOGRAPHY; ARTICLE; BRAIN ISCHEMIA; BRAIN VASOSPASM; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RATING SCALE; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE;

ADULT; ARGININE; BRAIN ISCHEMIA; ENDOTHELIN-1; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SUBARACHNOID HEMORRHAGE; VASODILATION; VASOSPASM, INTRACRANIAL;

EID: 84864612330     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.06.076     Document Type: Article

References (39)

1. Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. Journal of Neurosurgery 1988, 68:985-986.
2. Barone F.C., Globus M.Y., Price W.J., White R.F., Storer B.L., Feuerstein G.Z., Busto R., Ohlstein E.H. Endothelin levels increase in rat focal and global ischemia. Journal of Cerebral Blood Flow and Metabolism 1994, 14:337-342.
3. Brouns R., Marescau B., Possemiers I., Sheorajpanday R., De Deyn P.P. Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity. Neurochemical Research 2009, 34:1642-1649.
4. Creissard P., Proust F., Langlois O. Vasospasm diagnosis: theoretical and real transcranial Doppler sensitivity. Acta Neurochirurgica 1995, 136:181-185.
5. Crisi G., Colombo A., de Santis M., Guerzoni M.C., Calo M., Panzetti P. CT and cerebral ischemic infarcts. Correlations between morphological and clinical-prognostic findings. Neuroradiology 1984, 26:101-105.
6. Faraci F.M., Brian J.E., Heistad D.D. Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. American Journal of Physiology 1995, 269:H1522-H1527.
7. Fujimori A., Yanagisawa M., Saito A., Goto K., Masaki T., Mima T., Takakura K., Shigeno T. Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage. Lancet 1990, 336:633.
8. Gaetani P., Rodriguez y Baena R., Grignani G., Spanui G., Pacchiarini L., Paoletti P. Endothelin and aneurysmal subarachnoid haemorrhage: a study of subarachnoid cisternal cerebrospinal fluid. Journal of Neurology, Neurosurgery and Psychiatry 1994, 57:66-72.
9. Hamann G.F. Endothelins in acute ischemic stroke. Stroke 1998, 29:1257-1258.
10. Itoh S., Sasaki T., Asai A., Kuchino Y. Prevention of delayed vasospasm by an endothelin ETA receptor antagonist, BQ-123: change of ETA receptor mRNA expression in a canine subarachnoid hemorrhage model. Journal of Neurosurgery 1994, 81:759-764.
11. Jennett B., Bond M. Assessment of outcome after severe brain damage. Lancet 1975, 1:480-484.
12. Jung C.S., Iuliano B.A., Harvey-White J., Espey M.G., Oldfield E.H., Pluta R.M. Association between cerebrospinal fluid levels of asymmetric dimethyl-l-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. Journal of Neurosurgery 2004, 101:836-842.
13. Jung C.S., Oldfield E.H., Harvey-White J., Espey M.G., Zimmermann M., Seifert V., Pluta R.M. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2007, 107:945-950.
14. Karnofsky D.A., Burchenal J.H. The clinical evaluation of chemotherapeutic agents in cancer. Evaluation of Chemotherapeutic Agents 1949, 196. Columbia Univ. Press. M. CM (Ed.).
15. Kastner S., Oertel M.F., Scharbrodt W., Krause M., Boker D.K., Deinsberger W. Endothelin-1 in plasma, cisternal CSF and microdialysate following aneurysmal SAH. Acta Neurochirurgica (Wien) 2005, 147:1271-1279. [discussion 1279].
16. Kim P., Schini V.B., Sundt T.M., Vanhoutte P.M. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circulation Research 1992, 70:248-256.
17. Kobayashi H., Hayashi M., Kobayashi S., Kabuto M., Handa Y., Kawano H., Ide H. Cerebral vasospasm and vasoconstriction caused by endothelin. Neurosurgery 1991, 28:673-678. [discussion 678-9].
18. Lampl Y., Fleminger G., Gilad R., Galron R., Sarova-Pinhas I., Sokolovsky M. Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke 1997, 28:1951-1955.
19. Lysakowski C., Walder B., Costanza M.C., Tramer M.R. Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review. Stroke 2001, 32:2292-2298.
20. Maas R., Xanthakis V., Polak J.F., Schwedhelm E., Sullivan L.M., Benndorf R., Schulze F., Vasan R.S., Wolf P.A., Boger R.H., Seshadri S. Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort. Stroke 2009, 40:2715-2719.
21. Martens-Lobenhoffer J., Sulyok E., Czeiter E., Buki A., Kohl J., Firsching R., Troger U., Bode-Boger S.M. Determination of cerebrospinal fluid concentrations of arginine and dimethylarginines in patients with subarachnoid haemorrhage. Journal of Neuroscience Methods 2007, 164:155-160.
22. Matsumura Y., Ikegawa R., Tsukahara Y., Takaoka M., Morimoto S. Conversion of big endothelin-1 to endothelin-1 by two-types of metalloproteinases of cultured porcine vascular smooth muscle cells. Biochemical and Biophysical Research Communications 1991, 178:899-905.
23. Neuschmelting V., Marbacher S., Fathi A.R., Jakob S.M., Fandino J. Elevated level of endothelin-1 in cerebrospinal fluid and lack of nitric oxide in basilar arterial plasma associated with cerebral vasospasm after subarachnoid haemorrhage in rabbits. Acta Neurochirurgica (Wien) 2009, 151:795-801. [discussion 801-2].
24. Nirei H., Hamada K., Shoubo M., Sogabe K., Notsu Y., Ono T. An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs. Life Sciences 1993, 52:1869-1874.
25. Nishiyama Y., Ueda M., Katsura K., Otsuka T., Abe A., Nagayama H., Katayama Y. Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke. Journal of the Neurological Sciences 2010, 290:12-15.
26. Onoda K., Ono S., Ogihara K., Shiota T., Asari S., Ohmoto T., Ninomiya Y. Inhibition of vascular contraction by intracisternal administration of preproendothelin-1 mRNA antisense oligoDNA in a rat experimental vasospasm model. Journal of Neurosurgery 1996, 85:846-852.
27. Pluta R.M., Thompson B.G., Dawson T.M., Snyder S.H., Boock R.J., Oldfield E.H. Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. Journal of Neurosurgery 1996, 84:648-654.
28. Pluta R.M., Boock R.J., Afshar J.K., Clouse K., Bacic M., Ehrenreich H., Oldfield E.H. Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage. Journal of Neurosurgery 1997, 87:287-293.
29. Salonia R., Empey P.E., Poloyac S.M., Wisniewski S.R., Klamerus M., Ozawa H., Wagner A.K., Ruppel R., Bell M.J., Feldman K., Adelson P.D., Clark R.S., Kochanek P.M. Endothelin-1 is increased in cerebrospinal fluid and associated with unfavorable outcomes in children after severe traumatic brain injury. Journal of Neurotrauma 2010, 27:1819-1825.
30. Seifert V., Loffler B.M., Zimmermann M., Roux S., Stolke D. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. Journal of Neurosurgery 1995, 82:55-62.
31. Suzuki H., Sato S., Suzuki Y., Oka M., Tsuchiya T., Iino I., Yamanaka T., Ishihara N., Shimoda S. Endothelin immunoreactivity in cerebrospinal fluid of patients with subarachnoid haemorrhage. Annals of Medicine 1990, 22:233-236.
32. Suzuki Y., Kajita Y., Oyama H., Tanazawa T., Takayasu M., Shibuya M., Sugita K. Dysfunction of nitric oxide in the spastic basilar arteries after subarachnoid hemorrhage. Journal of the Autonomic Nervous System 1994, 49(Suppl.):S83-S87.
33. Thampatty B.P., Sherwood P.R., Gallek M.J., Crago E.A., Ren D., Hricik A.J., Kuo C.W., Klamerus M.M., Alexander S.A., Bender C.M., Hoffman L.A., Horowitz M.B., Kassam A.B., Poloyac S.M. Role of endothelin-1 in human aneurysmal subarachnoid hemorrhage: associations with vasospasm and delayed cerebral ischemia. Neurocritical Care 2011, 15:19-27.
34. Vallance P., Leone A., Calver A., Collier J., Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. Journal of Cardiovascular Pharmacology 1992, 20:S60-S62.
35. Worthmann H., Chen S., Martens-Lobenhoffer J., Li N., Deb M., Tryc A.B., Goldbecker A., Dong Q., Kielstein J.T., Bode-Boger S.M., Weissenborn K. High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke. Journal of Atherosclerosis and Thrombosis 2011, 18:753-761.
36. x and ADMA changes with focal ischemia, amelioration with the chaperonin GroEL. Neuroscience Letters 2007, 418:201-204.
37. Yamaura I., Tani E., Maeda Y., Minami N., Shindo H. Endothelin-1 of canine basilar artery in vasospasm. Journal of Neurosurgery 1992, 76:99-105.
38. Ziv I., Fleminger G., Djaldetti R., Achiron A., Melamed E., Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke 1992, 23:1014-1016.
39. Zuccarello M., Boccaletti R., Romano A., Rapoport R.M. Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 1998, 29:1924-1929.